Cargando…
Cardiovascular co-morbidity in rheumatic diseases
Patients with rheumatic disorders have an increased risk of cardiovascular disease (CVD). This excess co-morbidity is not fully explained by traditional risk factors. Disease severity is a major risk factor for CVD in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Sh...
Autores principales: | Turesson, Carl, Jacobsson, Lennart TH, Matteson, Eric L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515420/ https://www.ncbi.nlm.nih.gov/pubmed/18827910 |
Ejemplares similares
-
Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
por: Rydell, Emil, et al.
Publicado: (2023) -
Cardiovascular co-morbidity in patients with rheumatic diseases
por: Frostegård, Johan
Publicado: (2011) -
Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
por: Wadström, Karin, et al.
Publicado: (2020) -
Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021) -
Renal co-morbidity in patients with rheumatic diseases
por: Anders, Hans-Joachim, et al.
Publicado: (2011)